Paul Houri MS, MBA Bristol Myers Squibb

Paul was appointed Chief Quality Officer at Bristol Myers Squibb in September 2024. Prior to that he served as Vice President, Head of R&D Quality at BMS since 2023. A dynamic and strategic leader with more than 27 years of GxP quality and compliance experience, Paul has demonstrated an ability to foster a culture of quality excellence. Most notably, he has helped shape the Quality strategy with a focus on proactive, risk-based and scientific principles, leveraging innovation to enable end-to-end, sustainable quality performance. Prior to joining BMS, Paul held several senior-level Quality positions at Johnson & Johnson, most recently serving as the Head of BioResearch QA where he led risk-based quality and compliance oversight spanning preclinical, clinical and pharmacovigilance disciplines. During that time, he partnered with internal and external stakeholders to develop and implement innovative quality oversight, leveraging data analytics and technology solutions to deliver more effective, efficient and value-based quality outcomes. Prior to Johnson & Johnson, Paul held positions at Pfizer and Warner Lambert in both R&D and Manufacturing Quality. He holds a Bachelor’s in Biochemistry from the University of Scranton, an M.S. in Quality Engineering from Lehigh University and an MBA from St. John’s University.